NPDT Evaluation in Children With CFTR and (PSC)

NCT00179439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-12-13

No results posted yet for this study

Summary

The investigators hypothesize that PSC in children is associated with mutations and functional changes of the cystic fibrosis (CF) gene.

Conditions

Interventions

PROCEDURE

nasal potential difference testing

Sponsors & Collaborators

Principal Investigators

  • Harpreet Pall, MD · Boston Children's Hospital

  • Steven D Freedman, MD, PhD · Beth Israel Deaconess Medical Center

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2006-01-31
Completion
2006-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00179439 on ClinicalTrials.gov